Home/Filings/4/0001209191-20-009814
4//SEC Filing

OSTRACH MICHAEL S 4

Accession 0001209191-20-009814

CIK 0001029142other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:44 PM ET

Size

9.4 KB

Accession

0001209191-20-009814

Insider Transaction Report

Form 4
Period: 2020-02-12
OSTRACH MICHAEL S
VP, CBO, and General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2020-02-12+22,000153,604 total
  • Award

    Stock Option (Right to Buy)

    2020-02-12+105,000105,000 total
    Exercise: $5.42Exp: 2027-02-11Common Stock (105,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2020-02-12+22,0000 total
    Common Stock (22,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock that vested and converted to common stock on February 12, 2020.
  • [F2]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1
  • filerCIK 0001226066

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:44 PM ET
Size
9.4 KB